Where Will Vertex Pharmaceuticals Be in 5 Years
A lot can change in five years. Take Vertex Pharmaceuticals (NASDAQ: VRTX), for example. In late 2020, the big biotech company's approved products focused on one indication – cystic fibrosis (CF). And Vertex's market cap was nearly half what it is today.
It's reasonable to assume that much will change for the company by 2030 as well. Where will Vertex Pharmaceuticals be in five years? Here's my best guess.
Image source: Vertex Pharmaceuticals.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
374,90 €
1,49 %
Einseitige Meinung: Vertex Pharmaceuticals Inc. erhält nur Buy-Einschätzungen und keine Sell-Einschätzungen.
Das von der Community festgelegte Kursziel von 461 € für Vertex Pharmaceuticals Inc. bedeutet eine mögliche Steigerung um über 20% im Vergleich zu 374.9 €.
